1-3 of 3
Doaa El Demerdash
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The prolong trial: A two Phase randomized placebo-controlled trial to optimize rituximab response with dexamethasone and maintenance therapy with low dose rituximab in immune thrombocytopenia (ITP) patients

Free
Waleed Ghanima, Doaa El Demerdash, Henrik Frederiksen, James Bussel, Galina Tsykunova, Marc Michel, Hoa Tran, Carina Nassar, Bernadette Darne, Eirik Tjønnfjord, Tor Henrik Tvedt, Fehmi M'Sadek, Mervat Mattar, Abderraheem Khelif, Pål Holme
Journal: Blood
Blood (2025) 146 (Supplement 1): 736.
https://doi.org/10.1182/blood-2025-736
Published: 2025
Journal Articles

The holistic trial: A comprehensive evaluation of two second-line therapeutic approaches for immune thrombocytopenia (ITP) – a pragmatic randomized controlled trial

Free
Eirik Tjønnfjord, Inge Christoffer Olsen, Lamya Garabet, Hoa Tran, Doaa El Demerdash, Salam AlKindy, Geir Tjønnfjord, Waleed Ghanima
Journal: Blood
Blood (2025) 146 (Supplement 1): 8226.
https://doi.org/10.1182/blood-2025-8226
Published: 2025
Journal Articles

An Observational, Non-Interventional, Multicentre Study of Immune Thrombocytopenia: The Africa Middle East and Asian Immune Thrombocytopenia Registry

Free
Faisal Alsayegh, BMBCH, Mohammed Qari, Mervat Matar, Yasser Wali, Muhammad Kanani, Ali Al Madhani, Ibrahim Al Hijji, Doaa El Demerdash, Mahmoud Abbas
Journal: Blood
Blood (2017) 130 (Supplement 1): 4861.
https://doi.org/10.1182/blood.V130.Suppl_1.4861.4861
Published: 2017